Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hirotoshi Watanabe

Showing results (11-20 of 103) with videos related to

Pageof 11
Sort By:
Journal of Cardiology|August 10, 2023
Preferred monotherapy after short-term dual antiplatelet therapy: Systematic review and network meta-analysis of randomized trialsSatoshi Shoji, Toshiki Kuno, Hiroki Ueyama, et al.
The Journal of Invasive Cardiology|July 3, 2015
Patient-Specific Three-Dimensional Aortocoronary Model for Percutaneous Coronary Intervention of a Totally Occluded Anomalous Right Coronary ArteryHirotoshi Watanabe, Naritatsu Saito, Syojiro Tatsushima, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 20, 2020
Transradial vs. Transfemoral Percutaneous Coronary Intervention in Patients With or Without High Bleeding Risk CriteriaKo Yamamoto, Masahiro Natsuaki, Takeshi Morimoto, et al.
Journal of the American Heart Association|November 9, 2019
Ischemic and Bleeding Risk After Percutaneous Coronary Intervention in Patients With Prior Ischemic and Hemorrhagic StrokeMasahiro Natsuaki, Takeshi Morimoto, Hirotoshi Watanabe, et al.
The American Journal of Cardiology|April 10, 2018
Impact of Baseline Thrombocytopenia on Bleeding and Mortality After Percutaneous Coronary InterventionShinya Ito, Hirotoshi Watanabe, Takeshi Morimoto, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 26, 2018
Documented coronary atherothrombosis as the cause of death in post-discharge patients after coronary revascularizationHirotoshi Watanabe, Takeshi Morimoto, Hiroki Shiomi, et al.
BMJ (Clinical Research Ed.)|June 4, 2025
P2Y<sub>12</sub> inhibitor or aspirin after percutaneous coronary intervention: individual patient data meta-analysis of randomised clinical trialsDaniele Giacoppo, Felice Gragnano, Hirotoshi Watanabe, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 8, 2019
Percutaneous coronary intervention versus coronary arterial bypass grafting in patients with multi-vessel coronary revascularization (from the CREDO-Kyoto PCI/CABG registry/cohort-2)Hiroki Watanabe, Hiroki Shiomi, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|July 21, 2020
Clopidogrel Monotherapy vs. Aspirin Monotherapy Following Short-Term Dual Antiplatelet Therapy in Patients Receiving Everolimus-Eluting Coronary Stent ImplantationMasahiro Natsuaki, Takeshi Morimoto, Hirotoshi Watanabe, et al.
The American Journal of Cardiology|April 15, 2017
Incidence and Prognostic Impact of Heart Failure Hospitalization During Follow-Up After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial InfarctionTomohiko Taniguchi, Hiroki Shiomi, Takeshi Morimoto, et al.
Pageof 11

Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
Journal of Cardiology|August 10, 2023
Preferred monotherapy after short-term dual antiplatelet therapy: Systematic review and network meta-analysis of randomized trialsSatoshi Shoji, Toshiki Kuno, Hiroki Ueyama, et al.
The Journal of Invasive Cardiology|July 3, 2015
Patient-Specific Three-Dimensional Aortocoronary Model for Percutaneous Coronary Intervention of a Totally Occluded Anomalous Right Coronary ArteryHirotoshi Watanabe, Naritatsu Saito, Syojiro Tatsushima, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 20, 2020
Transradial vs. Transfemoral Percutaneous Coronary Intervention in Patients With or Without High Bleeding Risk CriteriaKo Yamamoto, Masahiro Natsuaki, Takeshi Morimoto, et al.
Journal of the American Heart Association|November 9, 2019
Ischemic and Bleeding Risk After Percutaneous Coronary Intervention in Patients With Prior Ischemic and Hemorrhagic StrokeMasahiro Natsuaki, Takeshi Morimoto, Hirotoshi Watanabe, et al.
The American Journal of Cardiology|April 10, 2018
Impact of Baseline Thrombocytopenia on Bleeding and Mortality After Percutaneous Coronary InterventionShinya Ito, Hirotoshi Watanabe, Takeshi Morimoto, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 26, 2018
Documented coronary atherothrombosis as the cause of death in post-discharge patients after coronary revascularizationHirotoshi Watanabe, Takeshi Morimoto, Hiroki Shiomi, et al.
BMJ (Clinical Research Ed.)|June 4, 2025
P2Y<sub>12</sub> inhibitor or aspirin after percutaneous coronary intervention: individual patient data meta-analysis of randomised clinical trialsDaniele Giacoppo, Felice Gragnano, Hirotoshi Watanabe, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 8, 2019
Percutaneous coronary intervention versus coronary arterial bypass grafting in patients with multi-vessel coronary revascularization (from the CREDO-Kyoto PCI/CABG registry/cohort-2)Hiroki Watanabe, Hiroki Shiomi, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|July 21, 2020
Clopidogrel Monotherapy vs. Aspirin Monotherapy Following Short-Term Dual Antiplatelet Therapy in Patients Receiving Everolimus-Eluting Coronary Stent ImplantationMasahiro Natsuaki, Takeshi Morimoto, Hirotoshi Watanabe, et al.
The American Journal of Cardiology|April 15, 2017
Incidence and Prognostic Impact of Heart Failure Hospitalization During Follow-Up After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial InfarctionTomohiko Taniguchi, Hiroki Shiomi, Takeshi Morimoto, et al.
Pageof 11